Abstract
Purpose
The current study summarized the clinical course and treatment outcomes of intestinal cancer in CD seen in our department and explored the steps to take in the future.
Methods
Subjects were patients who had been diagnosed with CD at our hospital and who underwent surgery in our department from 1985 to 2020.
Results
Thirty-one patients had CD and intestinal cancer, including 6 with cancer of the small intestine and 25 with cancer of the large intestine. In all six patients with cancer of the small intestine, the site where cancer or a tumor developed was at or near the site of the anastomosis made at a previous surgery. Of the 25 patients with cancer of the large intestine, 22 developed cancer in the rectum or anal region.
Conclusion
Many of the patients with cancer of the small intestine had previously undergone surgery, and the cancer developed at or near the site of the anastomosis. In patients who have previously undergone resection of the small intestine, the small intestine needs to be examined regularly. Cancer of the large intestine often developed in the rectum or anal region of our patients, so a detailed examination of the same site needs to be performed.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Yano Y, Matsui T, Hirai F, Okado Y, Sato Y, Tsurumi K, et al. Cancer risk in Japanese Crohn’s disease patients: investigation of the standardized incidence ratio. J Gastroenterol Hepatol. 2013;28:1300–5.
Mizushima T, Ohno Y, Nakajima K, Kai Y, Iijima H, Sekimoto M, et al. Malignancy in Crohn’s disease: incidence and clinical characteristics in Japan. Digestion. 2010;81:265–70.
Korelitz BI. Carcinoma of the intestinal tract in Crohn’s disease: results of survey conducted by the National Foundation for Ileitis and colitis. Am J Gastroenterol. 1983;78:44–6.
Gyde SN, Prior P, Macartney JC, Thompson H, Waterhouse JA, Allan RN. Malignancy in Crohn’s disease. Gut. 1980;21:1024–9.
Von Roon AC, Reese G, Teare J, Constantinides V, Darzi AW, Tekkis PP. The risk of cancer in patients with Crohn’s disease. Dis Colon Rectum. 2007;50:839–55.
Yano Y, Matsui T, Uno H, Hirai F, Futami K, Iwashita A. Risks and clinical features of colorectal cancer complicating Crohn’s disease in Japanese patients. J Gastroenterol Hepatol. 2008;23:1683–8.
Canavan C, Abrams KR, Mayberry J. Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn’s disease. Aliment Pharmacol Ther. 2006;23:1097–104.
Higashi D, Futami K, Kojima D, Futatsuki R, Ishibashi Y, Maekawa T, et al. Cancer of the small intestine in patients with Crohn’s disease. Anticancer Res. 2013;33:2977–80.
Kiran RP, Nisar PJ, Goldblum JR, Fazio VW, Remzi FH, Shen B, et al. Dysplasia associated with Crohn’s colitis: segmental colectomy or more extended resection? Ann Surg. 2012;256:221–6.
Choi PM, Zeling MP. Similarity of colorectal cancer in Crohn’s disease and ulcerative colitis: implications for carcinogenesis and prevention. Gut. 1994;35:950–4.
Stahl TJ, Schoetz DJ Jr, Roberts PL, Coller JA, Murray JJ, Silverman ML, et al. Crohn’s disease and carcinoma: increasing justification for surveillance? Dis Colon Rectum. 1992;35:850–6.
Higashi D, Katsuno H, Kimura H, Takahashi K, Ikeuchi H, Kono T, et al. Current state of and problems related to cancer of the intestinal tract associated with Crohn’s disease in Japan. Anticancer Res. 2016;36:3761–6.
Van Assche G, Dignass A, Bokemeyer B, Danese S, Gionchetti P, Moser G, et al. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part3; special situations. J Crohns Coitis. 2013;7:1–33.
Matsumoto T, Iwao Y, Igarashi M, Watanabe K, Otsuka K, Watanabe T, et al. Endoscopic and Chromoendoscopic atlas featuring dysplastic lesions in surveillance colonoscopy for patients with long-standing ulcerative colitis. Inflamm Bowel Dis. 2008;14:259–64.
Farraye FA, Odze RD, Eaden J, Itzkowitz SH, McCabe RP, Dassopoulos T, et al. AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology. 2010;138:738–45.
Hata K, Watanabe T, Kazama S, Suzuki K, Shinozaki M, Yokoyama T, et al. Earlier surveillance colonoscopy programme improves survival in patients with ulcerative colitis associated colorectal cancer: results of a 23-year surveillance programme in the Japanese population. BR J Cacner. 2003;89:1232–6.
Delbeke D, Martin WH. PET and PET-CT for evaluation of colorectal carcinoma. Semin Nucl Med. 2004;3:209–23.
Itzkowitz SH, Yio X. Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am J Physiol Gastrointest Liver Physiol. 2004;287:G7–17.
Hirano Y, Futami K, Higashi D, Mikami K, Maekawa T. Anorectal cancer surveillance in Crohn’s disease. J Anus Rectum Colon. 2018;2(4):145–54.
Funding
No specific funding was received.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no competing interests.
Ethical approval
The institutional ethical committee/IRB approval number: C21-01-014.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Higashi, D., Irie, H., Maki, T. et al. Small and large intestinal cancer in patients with Crohn’s disease studied by surgeons. Surg Today 53, 675–680 (2023). https://doi.org/10.1007/s00595-022-02605-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00595-022-02605-5